OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment
Chien-Ting Wu, Peter V. Lidsky, Yinghong Xiao, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1565-1576.e5
Open Access | Times Cited: 300

Showing 1-25 of 300 citing articles:

Risks and burdens of incident diabetes in long COVID: a cohort study
Yan Xie, Ziyad Al‐Aly
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 5, pp. 311-321
Open Access | Times Cited: 456

COVID-19-associated fungal infections
Martin Hoenigl, Danila Seidel, Rosanne Sprute, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1127-1140
Open Access | Times Cited: 327

COVID-19, Hyperglycemia, and New-Onset Diabetes
Kamlesh Khunti, Stefano Del Prato, Chantal Mathieu, et al.
Diabetes Care (2021) Vol. 44, Iss. 12, pp. 2645-2655
Open Access | Times Cited: 278

COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World
Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, et al.
Mycopathologia (2021) Vol. 186, Iss. 6, pp. 739-754
Open Access | Times Cited: 201

Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 169

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2174-2188.e5
Open Access | Times Cited: 161

Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103

Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK
Emma Rezel‐Potts, Abdel Douiri, Xiaohui Sun, et al.
PLoS Medicine (2022) Vol. 19, Iss. 7, pp. e1004052-e1004052
Open Access | Times Cited: 93

Innate metabolic responses against viral infections
Clovis S. Palmer
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1245-1259
Open Access | Times Cited: 73

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 69

Association of COVID-19 Infection With Incident Diabetes
Zaeema Naveed, Héctor Alexander Velásquez García, Stanley Wong, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e238866-e238866
Open Access | Times Cited: 53

Postacute Sequelae of SARS-CoV-2 in Children
Suchitra Rao, Rachel S. Gross, Sindhu Mohandas, et al.
PEDIATRICS (2024) Vol. 153, Iss. 3
Closed Access | Times Cited: 34

Advances in Pancreatic Islet Transplantation Sites for the Treatment of Diabetes
Fritz Cayabyab, Lina R. Nih, Eiji Yoshihara
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 84

Diabetes and COVID-19; A Bidirectional Interplay
Paraskevi Kazakou, Vaia Lambadiari, Ignatios Ikonomidis, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 64

Association of COVID-19 with diabetes: a systematic review and meta-analysis
Paddy Ssentongo, Yue Zhang, Lisa Witmer, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 62

The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data
Fares Qeadan, Benjamin Tingey, Jamie Egbert, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266809-e0266809
Open Access | Times Cited: 57

Mesenchymal stem cell treatment for COVID-19
Ruonan Xu, Zhiqian Feng, Fu‐Sheng Wang
EBioMedicine (2022) Vol. 77, pp. 103920-103920
Open Access | Times Cited: 55

The pathogenesis of coronavirus-19 disease
Alain Borczuk, Rhonda K. Yantiss
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 54

SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1
Jihoon Shin, Shinichiro Toyoda, Shigeki Nishitani, et al.
Metabolism (2022) Vol. 133, pp. 155236-155236
Open Access | Times Cited: 49

Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
Xue Li, Ziqi Zhang, Zhenling Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 49

The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes
Sheela N. Magge, Risa M. Wolf, Laura Pyle, et al.
The Journal of Pediatrics (2022) Vol. 251, pp. 51-59.e2
Open Access | Times Cited: 49

Pathogenesis of Type 1 Diabetes: Established Facts and New Insights
Ana Zajec, Katarina Trebušak Podkrajšek, Tine Tesovnik, et al.
Genes (2022) Vol. 13, Iss. 4, pp. 706-706
Open Access | Times Cited: 48

Limited extent and consequences of pancreatic SARS-CoV-2 infection
Verena van der Heide, Sonia Jangra, Phillip Cohen, et al.
Cell Reports (2022) Vol. 38, Iss. 11, pp. 110508-110508
Open Access | Times Cited: 48

Mechanisms of COVID-19 pathogenesis in diabetes
Chandrakala Aluganti Narasimhulu, Dinender K. Singla
AJP Heart and Circulatory Physiology (2022) Vol. 323, Iss. 3, pp. H403-H420
Open Access | Times Cited: 42

Page 1 - Next Page

Scroll to top